Embera NeuroTherapeutics, Inc. and Collaborators Publish Paper in Psychopharmacology Supporting its Novel Drug Combination, EMB-001, for Smoking Cessation
3/16/2012 7:34:32 AM
More...
|
Embera NeuroTherapeutics, Inc. Takes In $4.5 Million Series A Financing
8/15/2011 8:33:24 AM
More...
|
Embera NeuroTherapeutics, Inc.' Lead Candidate, EMB-001, Supported by $3.9M Grant from National Institute on Drug Abuse (NIDA)
10/1/2010 10:10:46 AM
More...
|
Embera NeuroTherapeutics, Inc.’ Lead Candidate, EMB-001, Supported by $3.9M Grant from National Institute on Drug Abuse
10/1/2010 6:32:28 AM
More...
|
Embera NeuroTherapeutics, Inc. Forms Clinical Development Collaboration with Exponential Pharma Ventures
2/16/2010 9:47:56 AM
More...
|
Embera NeuroTherapeutics, Inc. Announces Expansion of Management Team after Successful Completion of Pilot Study of Cocaine Addiction Treatment
7/20/2009 10:22:09 AM
More...
|
Embera NeuroTherapeutics, Inc. Scientific Advisory Board is Formed with Distinguished Professors Renowned in Addiction Research
5/18/2007 2:31:16 PM
More...
|